



CONGENITAL HEART DISEASELong-term results of right ventricular outflow tract reconstruction in
neonatal cardiac surgery: Options and outcomes
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Objectives: Neonatal surgery for tetralogy of Fallot and truncus arteriosus requires reconstruction of the right
ventricular outflow tract. Although the method of reconstruction is often dictated by the individual anatomy,
choices exist. This review examines the durability and outcomes of right ventricular outflow tract reconstruction
in the neonate.
Methods: This is a retrospective review of all 278 neonates with the diagnosis of tetralogy of Fallot and truncus
arteriosus undergoing right ventricular outflow tract reconstruction at a single center between 1990 and 2007. Di-
agnostic variants included tetralogy of Fallot/pulmonary stenosis (n ¼ 83), tetralogy of Fallot/pulmonary atresia
(n ¼ 81), and tetralogy of Fallot with absent pulmonary valve (n ¼ 17). Truncus arteriosus was present in 97 pa-
tients. Patients were analyzed on the basis of diagnosis and the method of right ventricular outflow tract recon-
struction: aortic homograft, pulmonary homograft, transannular patch, transannular patch with monocusp
pulmonary valve, and nontransannular patch. Freedom from reoperation/reintervention was determined by using
the log-rank test.
Results: The mean age at right ventricular outflow tract reconstruction was 11.8  8 days, and hospital survival
was 95.0% for the tetralogy of Fallot group and 90.7% for the truncus arteriosus group. Overall freedom from
reoperation and reintervention was 76.2%  14.8% in the nontransannular patch group and 59.5%  6.8% in
the transannular patch group; both were significantly greater than seen in patients receiving either aortic (0%) or
pulmonary (6.7% 4.2%) homografts (P<.05). There was no difference between aortic and pulmonary homo-
grafts. Among patients with tetralogy of Fallot/pulmonary stenosis, there was no difference in 10-year freedom
from reoperation/reintervention between the transannular (70.8%  7.4%) and nontransannular patch methods
(76.2%  14.8%, P ¼ .53). At 10 years, the diagnosis of tetralogy of Fallot/pulmonary stenosis was associated
with a greater freedom from reoperation/reintervention (68%  6.8%) when compared with tetralogy
of Fallot/pulmonary atresia (5.3%  4.3%, P ¼ .0001), tetralogy of Fallot/absent pulmonary valve (0%,
P ¼ .00315), or truncus arteriosus (4.2%  2.8%, P ¼ .0001). Eight patients (4 with tetralogy of Fallot/pulmo-
nary stenosis, 3 with tetralogy of Fallot/pulmonary atresia, and 1 with tetralogy of Fallot/absent valve) underwent
placement of a transannular patch with monocusp valve. Among this group, freedom from reoperation/reinterven-
tion is 41.7% 20.5% at 2.5 years. Monocusp function, as determined by means of echocardiographic analysis
obtained at 11.4  11.7 months (range, 0.3–31 months) showed an average monocusp gradient of 23.5  26.1
mm Hg, and 3 (37.5%) patients had more than moderate pulmonary regurgitation.
Conclusions: The durability of neonatal right ventricular outflow tract reconstruction is diagnosis and method
dependent. Anatomy allowing right ventricular outflow tract patching (either transannular or nontransannular)
provides a durability advantage compared with that seen with a homograft. There was no difference in perfor-
mance between aortic and pulmonary homografts, and the monocusp valve has limited durability and effective-
ness in neonatal right ventricular outflow tract surgery. The long-term outcomes of transannular and
nontransannular patching techniques for neonatal repair of tetralogy of Fallot/pulmonary stenosis are similar.From the Division of Cardiac Surgery and Cardiology, Children’s Hospital Boston and
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doi:10.1016/j.jtcvs.2008.10.058The Journal of Thoracic and CReconstruction of the right ventricular outflow tract (RVOT)
is a common constituent of neonatal cardiac surgery. With
the trend toward early repair and palliation of the RVOT1,2
in lesions including tetralogy of Fallot (TOF) and truncus ar-
teriosus (TA), reconstruction of the RVOT has become more
commonplace. A variety of techniques to achieve right ven-
tricle–pulmonary artery continuity has been devised, and the
method used is often determined by patient-specific anat-
omy. The methods of RVOT reconstruction include patch-
ing (transannular  monocusp valve and nontransannular)ardiovascular Surgery c Volume 138, Number 4 911




APV ¼ absent pulmonary valve
PA ¼ pulmonary atresia
PS ¼ pulmonary stenosis
RVOT ¼ right ventricular outflow tract
TA ¼ truncus arteriosus
TOF ¼ tetralogy of Fallot
VSD ¼ ventricular septal defect
and the use of a biologic right ventricle–pulmonary artery
conduit (aortic homograft, pulmonary homograft, or bovine
jugular vein graft).3-7
We sought to determine the durability of the various
methods of RVOT reconstruction performed in the neonatal
period. Specifically, freedom from reoperation and reinter-
vention as a consequence of diagnosis and method of repair
was determined, and we sought to identify clinical variables
that might influence the durability of neonatal RVOT recon-
structions.
MATERIALS AND METHODS
Institutional review board approval was obtained for the conduct of this
study. The study is a retrospective review of the cardiology/cardiac sur-
gery database, identifying all neonates who underwent RVOT reconstruc-
tion at Children’s Hospital Boston from 1990 to 2007. Medical charts,
operative records, postoperative reintervention reports, echocardiographic
and angiographic data, and correspondence with the pediatrician were re-
viewed. The patient data were then analyzed on the basis of diagnosis and
the method used for RVOT reconstruction. Reintervention was defined as
catheter based or surgical, with the intervention target being the RVOT.
Freedom from death or reintervention as a function of diagnosis and the
method of RVOT reconstruction was estimated by using multivariate anal-
ysis. Differences were determined by using either the log-rank test or c2
analysis.
Between 1990 and 2007, 278 patients less than 30 days of age and un-
dergoing surgical reconstruction of the RVOT were identified. There were
181 patients with TOF and 97 patients with TA. Diagnostic variants in-
cluded TOF with pulmonary stenosis (PS; n ¼ 83), TOF with pulmonary
atresia (PA; n ¼ 81), and TOF with absent pulmonary valve (APV; n ¼
17). TA was present in 97 patients, and patients were classified according
to the Van Praagh classification.8 Freedom from death and reintervention
was analyzed, and intragroup comparisons were made.
RESULTS
The mean age at the time of the operation for this group
was 11.8  8.2 days (range, 1–31 days; median, 9 days).
The in-hospital survival for the entire group was 93.5%
(260/278). There was a trend toward greater survival in the
later era, but this did not reach statistical significance
(90.6% for 1990–1997 vs 96.0% for 1997–2007, P ¼
.06949).
The TOF group of 181 patients consisted of the various
subsets indicated in Table 1. The average age at repair was
12.3  8.8 days (range, 1–31 days; median, 10 days). The
in-hospital survival for the TOF group was 95.0% (172/912 The Journal of Thoracic and Cardiovascular Su181). Once again, there was no era effect when comparing
survival during 1990 to 1997 and that during 1998 to 2007
(93.5% vs 96.1%; P ¼ .41789, c2 test).
The method of RVOT reconstruction among patients
with TOF included transannular patching in 97 (53.6%)
patients, a pulmonary homograft in 38 (20.9%) patients,
an aortic homograft in 34 (18.7%) patients, a nontransannu-
lar patch in 11 (6%) patients, and a valved bovine jugular
vein graft in 1 (0.6%) patient. The term nontransannular
patch is used to describe repairs that do not disrupt the
pulmonary valve annulus. Although this terminology gen-
erally refers to a pulmonary arteriotomy in isolation, in
some instances both a pulmonary arteriotomy and an infun-
dibulotomy were performed without breaching the pulmo-
nary annulus.
In the TOF/PS group (83 patients) 69 (83.1%) patients
underwent transannular patch placement, 11 (13.1%)
patients underwent nontransannular patch placement, and
3 (3.6%) patients had an aortic homograft inserted. In the
TOF/APV group (17 patients) 8 (47.1%) patients had a pul-
monary homograft reconstruction, 5 (29.4%) patients had
transannular patch placement, and 4 (23.5%) patients had
an aortic homograft used for reconstruction. In the TOF/
PA group (81 patients) 30 (37%) patients had a pulmonary
homograft, 27 (33.3%) patients had an aortic homograft, 23
(28.4%) patients had a transannular patch, and 1 (1.2%)
patient had a valved bovine jugular vein graft. One hundred
sixty-five patients had a ventricular septal defect (VSD)
closed in the TOF group in addition to the RVOT procedure;
it was closed with a fenestrated patch in 4 patients. The VSD
was left open in 16 patients (9 patients with TOF/PA/dimin-
utive pulmonary arteries, 5 patients with TOF/PA, 1 patient
with TOF/PA/discontinuous pulmonary arteries, and 1 pa-
tient with TOF/PS). Seventy-nine patients underwent rein-
tervention or reoperation. Of these, 66 patients had
catheter-based reinterventions, and 59 patients had reopera-
tions (Figure 1). Among the 59 patients who had a reopera-
tion, 33 had conduit change, 16 had augmentation of the
RVOT, 3 had repair of an RVOT pseudoaneurysm, 2 had
pulmonary valve implantation (secondary to increased right
ventricular volumes, as noted on magnetic resonance imag-
ing), 2 had conduit revision, 2 had left pulmonary artery aug-
mentation, and 1 had augmentation of the main pulmonary
artery.
Of the 59patientswhohad reoperations, 47 had adiagnosis
of TOF/PA, and 6 patients each had a diagnosis of TOF/PS
and TOF/APV (Figure 2). Of the 47 patients with TOF/PA
who had reoperations, 25 had conduits changed, and the
rest had augmentation of the main pulmonary artery,
RVOT, and/or branch pulmonary arteries. Of the 6 patients
with TOF/PS who had reoperations, 2 had a conduit change,
and the rest had augmentation of the RVOT. Of the 6 patients
with TOF/APV who had reoperations, 5 underwent conduit
replacement, and 1 had an RVOT false aneurysm repaired.rgery c October 2009
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TOF group was 32.5% (59/181); it was 47% (47/81) in
the TOF/PA group, 7.2% (6/83) in the TOF/PS group, and
35.2% (6/17) in the TOF/APV group. The catheter-based
reintervention rate was 36.4% (66/181) for the entire TOF
group, 58% (47/81) in the TOF/PA group, 16.8% (14/83)
in the TOF/PS group, and 29.4% (5/17) in the TOF/APV
group.
The freedom from reoperation was 88.9% 10.5% at 16
years in the nontransannular patch group and 63% 14.9%
TABLE 1. Specific diagnoses of patients in the TOF group
TOF group n ¼ 181
TOF/PS 83
TOF/PS 75




TOF/APV/discontinuous pulmonary artery 2
TOF/PA 81
TOF/PA 67
TOF/PA/diminutive pulmonary artery 9
TOF/PA/discontinuous pulmonary artery 3
TOF/PA/aortopulmonary window 1
TOF/PA/discontinuous and diminutive pulmonary arteries 1
TOF, Tetralogy of Fallot; PS, pulmonary stenosis; APV, absent pulmonary valve; PA,
pulmonary atresia.The Journal of Thoracic and Cat 14 years on the transannular patch group (P ¼ .3720,
log-rank test). The freedom from both reoperation and
reintervention was 76.2%  14.8% at 16 years in the non-
transannular patch group and 59.5%  6.8% at 14 years in
the transannular patch group (P ¼ .2325, log-rank test).
Freedom from both catheter-based reintervention and reop-
eration was 68.0% 6.8% at 16 years in the TOF/PS group,
5.3%  4.3% at 14 years in the TOF/PA group, 0.0% at
3.4 years in the TOF/APV group, and 4.2%  2.8% at 14
years in the TA group. The TOF/PS group had a longer free-
dom from reintervention and reoperation when compared
with the TOF/PA (P ¼ .0001), TOF/APV (P ¼ .0315),
and TA (P ¼ .0001, log-rank test) groups.
We examined the subgroup of patients who had transan-
nular patching with or without monocusp valve construc-
tion. Eight patients underwent transannular patch
placement with a monocusp, 4 of whom had TOF/PS, 3 of
whom had TOF/PA, and 1 who had TOF/APV. At follow-
up echocardiographic analysis at 11.4 11.7 months (range,
0.3–31 months) after the operation, the mean gradient was
23.5  26.1 mm Hg (range, 0–65 mm Hg), with 2 patients
having a gradient of more than 30 mm Hg, and 3 patients
having more than moderate pulmonary regurgitation. There
was no difference in reintervention and reoperation rates in
the transannular patch with monocusp reconstruction group
versus The transannular patch without monocusp recon-
struction group (41.7%  20.5% at 2.6 years vs 68.2% C
H
DFIGURE 1. Freedom from reintervention and reoperation based on the type of right ventricular outflow tract reconstruction.ardiovascular Surgery c Volume 138, Number 4 913
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DFIGURE 2. Freedom from reintervention and reoperation based on the primary diagnosis requiring right ventricular outflow tract reconstruction. TOF,
Tetralogy of Fallot; PS, pulmonary stenosis; APV, absent pulmonary valve; PA, pulmonary atresia; TA, truncus arteriosus.13.7% at 2.9 years; P ¼ .5886, log-rank test). Patients who
had RVOT reconstruction with either an aortic or pulmonary
homograft had significantly shorter freedom from reinter-
vention or reoperation when compared with those undergo-
ing all other types of RVOT reconstruction.
Ninety-seven patients with TA were included in this anal-
ysis. This included 46 patients with type IA, 31 patients with
type IIA, 4 patients with type IIIA, and 16 patients with type
IVA TA. The age at repair was 10.8 7.1 days (range, 2–31
days; median, 9 days). Given the variable and increased pul-
monary vascular resistance in the newborn period, we prefer
using homograft conduits in TA repair. The type of RVOT
procedure was an aortic homograft in 54 (55.7%) patients
and a pulmonary homograft in 42 (43.3%) patients, and 1
patient had a valved bovine jugular vein graft (1%). The
VSD was closed in all patients. The in-hospital survival
was 90.72% (88/97 patients). Again, although there was
a trend toward improved survival according to era (1990–
1997 vs 1998–2007: 86.28% vs 95.65%; P ¼ .11193, c2
test), this did not reach statistical significance. Fifty-six pa-
tients in the TA group underwent reoperations during the
course of the study, and 54 patients underwent catheter-
based reinterventions. The vast majority of reoperations
were for conduit change, and the majority of catheter reinter-
ventions were for conduit dilation.914 The Journal of Thoracic and Cardiovascular SurDISCUSSION
RVOT reconstruction is required in the management of
neonates with a variety of congenital heart diseases. We ex-
amined the type of RVOT reconstruction and the durability
of these reconstructions when performed in the neonatal
period for TOF and TA. The durability results for TA
have remained stable over the years, and our series reflected
the overall improved survival in the management of this le-
sion when compared with historical series.9 The majority of
patients with TOF/PS had transannular patch reconstruction
of the RVOT, and when compared with the other types of
patients with TOF, the TOF/PS group with transannular
patch reconstruction had the most durable RVOT recon-
struction. The majority of patients in the TOF/PA and
TOF/APV groups had the RVOT reconstructed with a valve
conduit; they had a significantly lower freedom from reinter-
vention and reoperation when compared with the TOF/PS
group.
The indications for reoperation are varied in this diverse
group. For patients undergoing reparative surgical interven-
tion, our general practice is to proceed with reintervention
when the RVOT gradient exceeds three quarters of systemic
pressure. Reintervention for palliated patients (ie, TOF/PA
with open VSD) was more complicated, including the
Qp:Qs and the ability to unifocalize aortopulmonarygery c October 2009
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Dcollateral arteries. All decisions with regard to reintervention
are unique in that they incorporate multiple factors, such
as ventricular function, tricuspid valve function, and right
ventricular dimensions. Examining the durability of the
RVOT reconstruction based on the operative technique
revealed that the nontransannular patch provided a
durability advantage when compared with valved conduits,
with a trend toward better durability when compared with
the transannular patch group. Inability to avoid transannular
patch in the newborn period has been cited as a disadvantage
of primary repair of TOF/PS in the neonate.10,11 The free-
dom from reoperation in the nontransannular patch group
was 88.9%  10.5% at 16 years, and it was 63% 
14.9% at 14 years in the transannular patch group (P ¼
.3720). The freedom from both reintervention and reopera-
tion was 76.2%  14.8% at 16 years versus 59.5% 
6.8% at 14 years (P ¼ .2325) in the nontransannular patch
group versus the transannular patch group. We failed to ap-
preciate a statistically significant durability advantage of
avoiding the transannular patch technique in the neonatal
period. The in-hospital survival in our series in the patients
with TOF was 93.5%, and it was 90.7% in the TA group.
These results are comparable with those reported in the liter-
ature.12-14 The use of a transannular patch in the TOF/PS
group was 83.1% (69/83), which, once again, is comparable
with results in a major series examining neonatal repair of
TOF (81% [13/16]).
RVOT reconstruction with a monocusp valve construc-
tion has been proposed as a potential technique to avoid re-
operation for pulmonary insufficiency. Anagnostopoulos
and colleagues6 have looked at the outcomes of patients
with TOF who had RVOT reconstruction with a monocusp
valve. They noted that the use of the monocusp valve re-
duced the incidence of clinically significant postoperative
pulmonary insufficiency. Brown and associates5 made an
observation similar to this: they noted that the use of a mono-
cusp valve during RVOT reconstruction prevented early and
midterm pulmonary insufficiency. However, the average
ages of the patients in these 2 series were 5.3 months and
3.3 years, respectively, which is significantly higher than
in our patient group. The promising result of such a tech-
nique in older children has not provided any durability ad-
vantage to neonates in our study.
We believe that the type of RVOT reconstruction con-
tinues to be lesion specific. Anatomy that is conducive for
nontransannular RVOT reconstruction would seem to pro-
vide a trend toward a durability advantage. However, we
did not appreciate any statistically significant disadvantage
of the transannular patch. One of the goals of this study
was to identify a type of neonatal RVOT reconstruction
that is lasting and durable. However, we have noted that
regardless of the type of technique used, there is a certain
degree of reoperation or reintervention required. The reoper-
ation rate for the TOF/PS subgroup was 7.2%, which isThe Journal of Thoracic and Ccomparable with that seen in most 1-stage and 2-stage re-
pairs of TOF/PS.11,13 The reoperation rates for the TOF/
PA and TOF/APV groups were 47% and 35.2%, respec-
tively. These results point to the palliative nature of the
RVOT reconstruction in these patient subsets. Certain tech-
niques might exhibit durability over the short term, but the
RVOT would need to be revised or a competent valve added
to the outflow tract at a future date.We perform neonatal cor-
rection of TOF, as opposed to palliative procedures, for
symptoms such as cyanosis or evidence of hypercyanotic
spells. There are several purported advantages of neonatal
repair, including the establishment of 2-ventricle circulation
early in life, the avoidance of cyanosis, and the establish-
ment of 2-ventricle circulation without the ventricular vol-
ume load of the shunt. Additional detriments of not
performing a complete neonatal repair include development
of right ventricular muscular hypertrophy, which could po-
tentially result in arrhythmogenic focus; distortion of branch
pulmonary arteries, requiring additional procedures; and the
presence of interstage mortality and morbidity.3,7,11,14,15
One study has also shown that the hospital charges for neo-
natal repair without an intervening shunt were significantly
lower.16 RVOT reconstruction in neonates with TOF/PS
can be accomplished with very little mortality and morbid-
ity. The rates of reintervention and reoperation in our series
are comparable with those noted in the literature. The most
durable type of RVOT reconstruction that we have noted
was the nontransannular patch technique.
The limitations of the study include the fact that it
included all different varieties of TOF. However, the main
inferences that we can draw from this retrospective review
include the fact that the nontransannular patch technique,
when possible, provides the most durability advantage.
The durability of conduits is limited, and they need to be
replaced with some regularity. We have used valve-sparing
repair in patients with TOF/PS who had a pulmonary an-
nulus larger than a z score of2. Further inspection of specific
valve-sparing nontransannular techniques would shed in-
sight into a potentially ‘‘curative’’ technique for the subset
of patients with TOF and PS.
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